期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 16, 期 21, 页码 5616-5620出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2006.08.026
关键词
prolyl hydroxylase inhibitors; HIF-1 alpha; hypoxia; ischemia; peripheral arterial disease (PAD); anemia
Structure-guided de novo drug design led to the identification of a novel series of substituted pyridine derivatives as HIF-1 alpha prolyl hydroxylase inhibitors. Pyridine carboxyamide derivatives bearing a substituted aryl group at the 5-position of the pyridine ring show appreciable activity, while constraining the side chain by placing a pyrazole carboxylic acid generated a potent lead series with consistent activity against EGLN-1. (c) 2006 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据